Marker Therapeutics
MRKR
MRKR
63 hedge funds and large institutions have $29.4M invested in Marker Therapeutics in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
-2
Holders Change %
-3.08%
% of All Funds
1.29%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
8
Increased
20
Reduced
14
Closed
10
Calls
$542K
Puts
$25K
Net Calls
+$517K
Net Calls Change
+$359K
Top Buyers
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$462K |
| 2 |
Nuveen Asset Management
Chicago,
Illinois
|
+$254K |
| 3 |
Renaissance Technologies
New York
|
+$176K |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$137K |
| 5 |
BlackRock
New York
|
+$130K |
Top Sellers
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$2.55M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$186K |
| 3 |
State Street
Boston,
Massachusetts
|
-$106K |
| 4 |
VWM
Vigilare Wealth Management
Scottsdale,
Arizona
|
-$104K |
| 5 |
D.E. Shaw & Co
New York
|
-$67K |
